The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
Open accessAbstract
BACKGROUND: The extent to which diabetes mellitus or hyperglycemia is related to risk of death from cancer or other nonvascular conditions is uncertain. METHODS: We calculated hazard ratios for cause-specific death, according to baseline diabetes status or fasting glucose level, from individual-participant data on 123,205 deaths among 820,900 people in 97 prospective studies. RESULTS: After adjustment for age, sex, smoking status, and body-mass index, hazard ratios among persons with diabetes as compared with persons without diabetes were as follows: 1.80 (95% confidence interval [CI], 1.71 to 1.90) for death from any cause, 1.25 (95% CI, 1.19 to 1.31) for death from cancer, 2.32 (95% CI, 2.11 to 2.56) for death from vascular causes, and 1.73 (95% CI, 1.62 to 1.85) for death from other causes. Diabetes (vs. no diabetes) was moderately associated with death from cancers of the liver, pancreas, ovary, colorectum, lung, bladder, and breast. Aside from cancer and vascular disease, diabetes (vs. no diabetes) was also associated with death from renal disease, liver disease, pneumonia and other infectious diseases, mental disorders, nonhepatic digestive diseases, external causes, intentional self-harm, nervous-system disorders, and chronic obstructive pulmonary disease. Hazard ratios were appreciably reduced after further adjustment for glycemia measures, but not after adjustment for systolic blood pressure, lipid levels, inflammation or renal markers. Fasting glucose levels exceeding 100 mg per deciliter (5.6 mmol per liter), but not levels of 70 to 100 mg per deciliter (3.9 to 5.6 mmol per liter), were associated with death. A 50-year-old with diabetes died, on average, 6 years earlier than a counterpart without diabetes, with about 40% of the difference in survival attributable to excess nonvascular deaths. CONCLUSIONS: In addition to vascular disease, diabetes is associated with substantial premature death from several cancers, infectious diseases, external causes, intentional self-harm, and degenerative disorders, independent of several major risk factors. (Funded by the British Heart Foundation and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prediabetes is linked with increased risks of major manifestations of vascular disease, but it remains unclear whether the elevated disease risks depend on development of clinical diabetes.84,85”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [85]
In the citing paper
“A recent individual-level evidence from prospective studies suggests that fasting hyperglycaemia (figure 3), postload glucose, and A1c are all robust predictors of vascular mortality86,88,89 and, according to multivariable adjusted analyses, these associations are independent of vascular risk factors, such as obesity, blood pressure, triglyceride and lipoproteins.84,85,87”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [85]
In the citing paper
“The study found that a 50-year-old with T2DM died, on average, 6 years earlier than an individual without T2DM, with about 40% of the difference in survival attributable to excess non-vascular deaths.95”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [95]
In the citing paper
“Aside from CV death, results from the Emerging Risk Factors Collaboration, including 820 900 people, demonstrate that T2DM is independently associated with increased risk of death from several cancers (i.e.liver, pancreas, ovary, colorectum, lung, bladder, and breast), renal and liver disease, pneumonia and other infectious diseases, mental and nervous system disorders, non-hepatic digestive dis”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [95]
In the citing paper
“These are consistent with downward secular trends in cardiovascular disease and improvements in mortality and are in line with previously reported estimates of the reduction in life expectancy due to diabetes [23].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2014) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,609
Mortality in relation to smoking: 40 years' observations on male British doctors
Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ · doi:10.1136/bmj.309.6959.901 · Cited by 5,932
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Self-citationMortality in relation to smoking: 50 years' observations on male British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · BMJ · doi:10.1136/bmj.38142.554479.ae · Cited by 2,920
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
(2009) · JAMA · doi:10.1001/jama.2009.1063 · Cited by 1,753
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,010
Figueroa, J. D., García‐Closas, M., Humphreys, M. K., Platte, R., Hopper, J. L., Southey, M. C., Apicella, C., Hammet, F., Schmidt, M. K., Broeks, A., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr368 · Cited by 80
Type 2 diabetes and viral infection; cause and effect of disease
Wensveen, T. T., Gašparini, D., Rahelić, D., & Wensveen, F. M. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108637 · Cited by 80
Type 2 Diabetes and 10-Year Risk of Dementia and Cognitive Impairment Among Older Mexican Americans
Mayeda, E. R., Haan, M. N., Kanaya, A. M., Yaffe, K. S., & Neuhaus, J. M. (2013) · Diabetes Care · doi:10.2337/dc12-2158 · Cited by 81
Herrington, W. G., Alegre-Díaz, J., Wade, R. L., Gnatiuc, L., Ramírez-Reyes, R., Hill, M., Solano-Sánchez, M., Baigent, C., Lewington, S., Collins, R., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30050-0 · Cited by 81
Warren, B., Rebholz, C. M., Sang, Y., Lee, A. K., Coresh, J., Selvin, E., & Grams, M. E. (2018) · Diabetes Care · doi:10.2337/dc18-0277 · Cited by 79
Cardiovascular benefits of GLP-1 agonists in type 2 diabetes: a comparative review
Boyle, J. G., Livingstone, R., & Petrie, J. R. (2018) · Clinical Science · doi:10.1042/cs20171299 · Cited by 81
Sharma, A., Green, J. B., Dunning, A., Lokhnygina, Y., Al-Khatib, S. M., Lopes, R. D., Buse, J. B., Lachin, J. M., Van de Werf, F., Armstrong, P. W., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1091 · Cited by 80
Comorbidity of Cognitive Impairment and Late-Life Depression Increase Mortality
Georgakis, M. K., Papadopoulos, F. C., Protogerou, A. D., Pagonari, I., Sarigianni, F., Biniaris-Georgallis, S.-I., Kalogirou, E. Ι., Thomopoulos, T. P., Kapaki, E. N., Papageorgiou, C., et al. (2016) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716632913 · Cited by 78
Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study
Ferrannini, G., Manca, M. L., Magnoni, M., Andreotti, F., Andreini, D., Latini, R., Maseri, A., Maggioni, A. P., Ostroff, R. M., Williams, S. A., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1902 · Cited by 78
for the Relationship between Cardiovascular disease and Brachial-ankle Pulse Wave Velocity (baPWV) in Patients with Type 2 Diabetes (REBOUND) Study Group, Kim, J. M., Kim, S. S., Kim, I. J., Kim, J. H., Kim, B. H., Kim, M.-K., Lee, S. H., Lee, C. W., Kim, M. C., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01120-6 · Cited by 80
Hu, S., Wang, J., Liu, E., Zhang, X., Xiang, J., Li, W., Wei, P., Zeng, J., Zhang, Y., & Ma, X. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106481 · Cited by 80
Cardiovascular Disease in Diabetes and Chronic Kidney Disease
Swamy, S., Noor, S. M., & Mathew, R. O. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12226984 · Cited by 88
Recomendaciones preventivas cardiovasculares
Galán, Á. M. M., Cuixart, C. B., Álvarez, F. V., Pérez, J. N., Lobos-Bejarano, J. M., Sánchez-Pinilla, R. O., Rioboó, E. M., Banegas, J. R. B., Orozco‐Beltrán, D., & Gil-Guillén, V. F. (2012) · Atención Primaria · doi:10.1016/s0212-6567(12)70010-0 · Cited by 78
Saulnier, P., Gand, E., Ragot, S., Ducrocq, G., Halimi, J., Hulin-Delmotte, C., Llaty, P., Montaigne, D., Rigalleau, V., Roussel, R., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2580 · Cited by 78
Al-Salameh, A., Chanson, P., Bucher, S., Ringa, V., & Becquemont, L. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.08.007 · Cited by 77
Predicting and preventing heart failure in type 2 diabetes
Pandey, A., Khan, M. S., Patel, K. V., Bhatt, D. L., & Verma, S. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00128-6 · Cited by 84
Diabetes and Breast Cancer Subtypes
Bronsveld, H. K., Jensen, V., Vahl, P., Bruin, M. L. D., Cornelissen, S., Sanders, J., Auvinen, A. P., Haukka, J. K., Andersen, M. T., Vestergaard, P., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170084 · Cited by 76
Nie, J., Yu, C., Guo, Y., Pei, P., Chen, L., Pang, Y., Du, H., Yang, L., Chen, Y., Yan, S., et al. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab006 · Cited by 77
Concurrent diabetes and heart failure: interplay and novel therapeutic approaches
Karwi, Q. G., Ho, K. L., Pherwani, S., Ketema, E. B., Sun, Q., & Lopaschuk, G. D. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab120 · Cited by 80
Cancer risk in patients with type 2 diabetes mellitus and their relatives
Liu, X., Hemminki, K., Försti, A., Sundquist, K., Sundquist, J., & Ji, J. (2015) · International Journal of Cancer · doi:10.1002/ijc.29440 · Cited by 79
Circulating adiponectin levels and risk of type 2 diabetes in the Japanese
Yamamoto, S., Matsushita, Y., Nakagawa, T., Hayashi, T., Noda, M., & Mizoue, T. (2014) · Nutrition and Diabetes · doi:10.1038/nutd.2014.27 · Cited by 80
Doucet, J., Floch, J. P. L., Bauduceau, B., & Verny, C. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.07.001 · Cited by 76
Diabetes mellitus and the risk of bladder cancer
Xu, Y., Huo, R., Chen, X., & Yu, X. (2017) · Medicine · doi:10.1097/md.0000000000008588 · Cited by 76
Ferrannini, G., De Bacquer, D., De Backer, G., Kotseva, K., Mellbin, L., Wood, D., Rydén, L., collaborators, E. V., Gale, C. P., Beleslin, B., et al. (2020) · Diabetes Care · doi:10.2337/dc19-2165 · Cited by 75
Vijayakumar, S., Divya, M., Vaseeharan, B., Chen, J., Biruntha, M., Silva, L. P., Durán‐Lara, E. F., Shreema, K., Ranjan, S., & Dasgupta, N. (2020) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/s10904-020-01713-4 · Cited by 75
Diabetes and Pancreatic Cancer—A Dangerous Liaison Relying on Carbonyl Stress
Menini, S., Iacobini, C., Vitale, M., Pesce, C. M., & Pugliese, G. (2021) · Cancers · doi:10.3390/cancers13020313 · Cited by 79
Liu, H., Liu, J., Liu, J., Xin, S., Lyu, Z., & Fu, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.828581 · Cited by 76
Anhê, F. F., Zlitni, S., Zhang, S., Choi, B. S.-Y., Chen, C. Y., Foley, K. P., Barra, N. G., Surette, M. G., Biertho, L. D., Richard, D., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-328185 · Cited by 82
Prolonged Survival in Patients with Lung Cancer with Diabetes Mellitus
Hatlen, P., Grønberg, B. H., Langhammer, A., Carlsen, S. M., & Amundsen, T. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31822a75be · Cited by 79
Epidemiology of Cardiovascular Risk Factors in Asian Countries
Nguyen, H. N., Fujiyoshi, A., Abbott, R. D., & Miura, K. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-1292 · Cited by 73
Wang, M., Hu, R., Wu, H., Pan, J., Gong, W., Guo, L., Zhong, J.-M., Fei, F.-R., & Yu, M. (2015) · Scientific Reports · doi:10.1038/srep11503 · Cited by 74
Mor, A., Dekkers, O. M., Nielsen, J. S., Beck‐Nielsen, H., Sørensen, H. T., & Thomsen, R. W. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx049 · Cited by 75
Yi, S., Park, S., Lee, Y., Park, H.-J., Balkau, B., & Yi, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-08498-6 · Cited by 76
Current perspectives on cardiovascular outcome trials in diabetes
on behalf of the D&CVD EASD Study Group, Schnell, O., Rydén, L., Standl, E., & Ceriello, A. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0456-8 · Cited by 73
Milenković, T., Bozhinovska, N., Μacut, D., Bjekić-Macut, J., Rahelić, D., Velija-Ašimi, Z., & Bureković, A. (2021) · Nutrients · doi:10.3390/nu13041307 · Cited by 97
Sp, F.-H., Vatcheva, K. P., Laing, S. T., Hossain, M. M., Mh, R., & Cl, H. (2012) · Preventing Chronic Disease · doi:10.5888/pcd9.110298 · Cited by 78
Cancer-drug induced insulin resistance: Innocent bystander or unusual suspect
Ariaans, G., de Jong, S., Gietema, J. A., Lefrandt, J. D., de Vries, E. G. E., & Jalving, M. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.02.007 · Cited by 78
Cleveland, R. J., North, K. E., Stevens, J., Teitelbaum, S. L., Neugut, A. I., & Gammon, M. D. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-9989-7 · Cited by 74
Kong, A. P. S., Yang, X., Luk, A. O. Y., Ronald, C. W., So, W. Y., Ozaki, R., Ting, R. Z. W., Cheung, K. K.-T., Ho, C. S., Chan, M. H. M., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2507 · Cited by 73
Research Resource: The Pdx1 Cistrome of Pancreatic Islets
Khoo, C., Yang, J., Weinrott, S. A., Kaestner, K. H., Naji, A., Schug, J., & Stoffers, D. A. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1231 · Cited by 72
A systematic review of trends in all-cause mortality among people with diabetes
Chen, L., Islam, R. M., Wang, J. N., Hird, T. R., Pavkov, M. E., Gregg, E. W., Salim, A., Tabesh, M., Koye, D. N., Harding, J. L., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05199-0 · Cited by 73
Zhang, M., Sara, J. D. S., Wang, F., Liu, L., Su, L.-X., Jing, Z., Wu, X., & Liu, J. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0214-3 · Cited by 71
Molecular Mechanisms Linking Diabetes to the Accelerated Development of Atherosclerosis
Zeadin, M. G., Petlura, C., & Werstuck, G. H. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.06.001 · Cited by 77
Joshu, C. E., Prizment, A. E., Dluzniewski, P. J., Menke, A., Folsom, A. R., Coresh, J., Yeh, H. C., Brancati, F. L., Platz, E. A., & Selvin, E. (2011) · International Journal of Cancer · doi:10.1002/ijc.27394 · Cited by 76
MicroRNA-185 Targets SOCS3 to Inhibit Beta-Cell Dysfunction in Diabetes
Bao, L., Fu, X., Mingwen, S., Wang, Y., Ma, R., Ren, X., & Lv, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116067 · Cited by 76
Usual blood pressure, atrial fibrillation and vascular risk: evidence from 4.3 million adults
Emdin, C. A., Anderson, S. G., Salimi-Khorshidi, G., Woodward, M., MacMahon, S., Dwyer, T., & Rahimi, K. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw053 · Cited by 73
The Landscape of Diabetic Kidney Disease in the United States
Duru, O. K., Middleton, T. R., Tewari, M. K., & Norris, K. C. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0980-x · Cited by 75
Cardiovascular Disease in Diabetes Mellitus
Szuszkiewicz-Garcia, M., & Davidson, J. A. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.001 · Cited by 76
SARS-CoV-2 and diabetes: New challenges for the disease
Cristelo, C., Azevedo, C., Marques, J. M., Nunes, R., & Sarmento, B. F. C. C. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108228 · Cited by 73
Cantiello, F., Cicione, A. M., Salonia, A., Riccardo Autorino, B., Nunzio, C. D., Briganti, A., Gandaglia, G., Dell’Oglio, P., Capogrosso, P., & Damiano, R. (2014) · International Journal of Urology · doi:10.1111/iju.12644 · Cited by 72
Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies
Zhu, Z., Zhang, X., Shen, Z., Zhong, S., Wang, X., Lu, Y., & Chen, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056662 · Cited by 72
Kaur, P., Rizk, N. M., Ibrahim, S., Younes, N., Uppal, A., Dennis, K., Karve, T. M., Blakeslee, K., Kwagyan, J., Zirie, M. A., et al. (2012) · Journal of Proteome Research · doi:10.1021/pr300798z · Cited by 72
Metabolic complications of obesity
Pedersen, S. D. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.02.004 · Cited by 75
Metformin Use in Prediabetes Among U.S. Adults, 2005–2012
Tseng, E., Yeh, H.-C., & Maruthur, N. M. (2017) · Diabetes Care · doi:10.2337/dc16-1509 · Cited by 72
Marx, N., McGuire, D. K., Perkovic, V., Woerle, H., Broedl, U. C., von Eynatten, M., George, J. T., & Rosenstock, J. (2017) · Diabetes Care · doi:10.2337/dc17-0068 · Cited by 73
Cardiovascular Disease and Diabetic Kidney Disease
Maqbool, M., Cooper, M. E., & Jandeleit-Dahm, K. A. M. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.02.003 · Cited by 73
Role of Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Cancer Risk
Yamagishi, S., Matsui, T., & Fukami, K. (2014) · Rejuvenation Research · doi:10.1089/rej.2014.1625 · Cited by 72
Effects of glucose-lowering agents on vascular outcomes in type 2 diabetes: A critical reappraisal
Scheen, A. J., & Charbonnel, B. H. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.03.004 · Cited by 71
Skriver, M. V., Sandbæk, A., Kristensen, J. K., & Støvring, H. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2014-000060 · Cited by 72
Kynurenines as predictors of acute coronary events in the Hordaland Health Study
Eussen, S. J. P. M., Ueland, P. M., Vollset, S. E., Nygard, O. K., Midttun, Ø., Sulo, G., Ulvik, A., Meyer, K., Pedersen, E. R., & Tell, G. S. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.413 · Cited by 74
Myonectin Predicts the Development of Type 2 Diabetes
Li, K., Liao, X., Wang, K., Mi, Q., Zhang, T., Jia, Y., Xu, X., Luo, X., Zhang, C., Liu, H., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01604 · Cited by 73
Development and prognosis of hepatocellular carcinoma in patients with diabetes
Nakatsuka, T., & Tateishi, R. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0095 · Cited by 73
Aune, D., Schlesinger, S., Mahamat‐Saleh, Y., Zheng, B., Udeh‐Momoh, C. T., & Middleton, L. T. (2023) · European Journal of Epidemiology · doi:10.1007/s10654-023-00970-0 · Cited by 73
Macrophages and T cells in metabolic disorder-associated cancers
Taranto, D., Kloosterman, D. J., & Akkari, L. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00743-1 · Cited by 81
Minicozzi, P., Berrino, F., Sebastiani, F., Falcini, F., Vattiato, R., Cioccoloni, F., Calagreti, G., Fusco, M., Vitale, M. F., Tumino, R., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.08.004 · Cited by 70
Sluik, D., Boeing, H., Li, K., Kaaks, R., Johnsen, N. F., Tjønneland, A., Arriola, L., Barricarte, A., Masala, G., Grioni, S., et al. (2014) · Diabetologia · doi:10.1007/s00125-013-3074-y · Cited by 70
Diabetes hinders community-acquired pneumonia outcomes in hospitalized patients
Martins, M., Boavida, J. M., Raposo, J. F., Froes, F., Nunes, B., Ribeiro, R. T., Macedo, M. P., & Penha‐Gonçalves, C. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000181 · Cited by 70
Prevalencia de obesidad y diabetes en adultos españoles, 1987-2012
Basterra-Gortari, F. J., Bes‐Rastrollo, M., Ruiz‐Canela, M., Gea, A., & Martínez‐González, M. Á. (2017) · Medicina Clínica · doi:10.1016/j.medcli.2016.11.022 · Cited by 76
Metabolic syndrome and liver-related events: a systematic review and meta-analysis
Ren, H., Wang, J., Gao, Y., Yang, F., & Huang, W. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0366-3 · Cited by 70
Identifying Novel Biomarkers for Cardiovascular Events or Death in People With Dysglycemia
Gerstein, H. C., Paré, G., McQueen, M. J., Haenel, H., Lee, S. F., Pogue, J., Maggioni, A. P., Yusuf, S., & Hess, S. (2015) · Circulation · doi:10.1161/circulationaha.115.015744 · Cited by 69
Cho, J., Scragg, R. K. R., Pandol, S. J., Goodarzi, M. O., & Petrov, M. S. (2019) · Diabetes Care · doi:10.2337/dc19-0145 · Cited by 69
Longato, E., Fadini, G. P., Sparacino, G., Avogaro, A., Tramontan, L., & Camillo, B. D. (2021) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2021.3065756 · Cited by 73
Cheng, H.-C., Chang, T., Su, W., Tsai, H., & Wang, J. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101089 · Cited by 70
Wester, A., Shang, Y., Grip, E. T., Matthews, A., & Hagström, H. (2024) · Gut · doi:10.1136/gutjnl-2023-330962 · Cited by 81
Ribe, A. R., Laursen, T. M., Sandbæk, A., Charles, M., Nordentoft, M., & Vestergaard, M. (2014) · Psychological Medicine · doi:10.1017/s0033291714000634 · Cited by 70
Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease
Bertot, L. C., & Adams, L. A. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1549989 · Cited by 68
The burden of diabetes and hyperglycemia in Brazil: a global burden of disease study 2017
Duncan, B. B., Cousin, E., Naghavi, M., Afshin, A., França, E. B., Passos, V. M. D. A., Malta, D. C., Nascimento, B. R., & Schmidt, M. I. (2020) · Population Health Metrics · doi:10.1186/s12963-020-00209-0 · Cited by 70
Jiang, H., Yao, Q., An, Y., Fan, L., Wang, J., & Li, H. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153823 · Cited by 69
Rizvi, A. A., & Rizzo, M. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s351982 · Cited by 73
Triglycerides/HDL cholesterol ratio and type 2 diabetes incidence: Panasonic Cohort Study 10
Yuge, H., Okada, H., Hamaguchi, M., Kurogi, K., Murata, H., Ito, M., & Fukui, M. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02046-5 · Cited by 68
Bianchi, C., & Prato, S. D. (2011) · The Review of Diabetic Studies · doi:10.1900/rds.2011.8.432 · Cited by 67
Importance of Beta Cell Function for the Treatment of Type 2 Diabetes
Saisho, Y. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3030923 · Cited by 75
Definition of intervention points in prediabetes
Ferrannini, E. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70175-x · Cited by 70
Obesity, diabetes and pneumonia: the menacing interface of non‐communicable and infectious diseases
Fisher‐Hoch, S. P., Mathews, C. E., & McCormick, J. B. (2013) · Tropical Medicine & International Health · doi:10.1111/tmi.12206 · Cited by 69
Rethinking good cholesterol: a clinicians' guide to understanding HDL
Xiang, A. S., & Kingwell, B. A. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30003-8 · Cited by 70
Mattioli, A. V., Sciomer, S., Moscucci, F., Maiello, M. R., Cugusi, L., Gallina, S., Dei, A., Lombardi, C., Pengo, M. F., Parati, G., et al. (2019) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000831 · Cited by 71
Alagebrium and Complications of Diabetes Mellitus
Toprak, Ç., & Yiğitaslan, S. (2019) · Eurasian Journal of Medicine · doi:10.5152/eurasianjmed.2019.18434 · Cited by 67
Ling, S., Brown, K., Miksza, J. K., Howells, L. M., Morrison, A., Issa, E., Yates, T. E., Khunti, K., Davies, M. J., & Zaccardi, F. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.09.023 · Cited by 70
Liang, R., Feng, X., Shi, D., Yang, M., Yu, L., Liu, W., Zhou, M., Wang, X., Qiu, W., Fan, L., et al. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3572 · Cited by 68
Excess Mortality among Persons with Type 2 Diabetes
Lind, M., Wedel, H., & Rosengren, A. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1515130 · Cited by 67
Chou, F.-H., Larsson, M., Hsiao, M.-H., Chen, Y., Röding, M., Nydén, M., & Liu, D. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.036 · Cited by 66
Chan, J. C. N., So, W., Ronald, C. W., Tong, P. C. Y., Wong, R. Y. M., & Yang, X. (2011) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-011-0172-6 · Cited by 65
Roussel, R., Steg, P. G., Mohammedi, K., Marre, M., & Potier, L. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13033 · Cited by 66
Diabetes and Overall Survival among Breast Cancer Patients in the U.S. Military Health System
Shao, S., Gill, A. A., Zahm, S. H., Jatoi, I., Shriver, C. D., McGlynn, K. A., & Zhu, K. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0439 · Cited by 65
Yang, J., Yang, A., Cheng, N., Huang, W., Huang, P., Liu, N., & Bai, Y. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.126940 · Cited by 65
Diabetic foot disease in the United Kingdom: about time to put feet first
McInnes, A. D. (2012) · Journal of Foot and Ankle Research · doi:10.1186/1757-1146-5-26 · Cited by 67
Miller, A. M., Purves, D. G., McConnachie, A., Asquith, D. L., Batty, G. D., Burns, H., Cavanagh, J., Ford, I., McLean, J. S., Packard, C. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047830 · Cited by 66
Anti-depressant effect of hesperidin in diabetic rats
El‐Marasy, S. A., Abdallah, H. M. I., El-Shenawy, S. M. A., El-Khatib, A. S., El‐Shabrawy, O. A., & Kenawy, S. A. (2014) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0281 · Cited by 65
Abnormal Myocardial Dietary Fatty Acid Metabolism and Diabetic Cardiomyopathy
Carpentier, A. C. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.12.029 · Cited by 66
Ahmed, N., Choe, Y. S., Mustad, V. A., Chakraborty, S., Goates, S., Luo, M., & Mechanick, J. I. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000471 · Cited by 66
Metadata
- Authors
- The Emerging Risk Factors Collaboration
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- The Emerging Risk Factors Collaboration
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-03-03
- Volume
- 364
- Issue
- 9
- Pages
- 829-841
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4109980
- OpenAlex
- W2126919962
- Semantic Scholar
- a89247dcde559e5839cef19b130059e2ad9abc75
- Cited by
- 2,726
- References
- 40
- Citations by year
- 2026: 102 · 2025: 138 · 2024: 186 · 2023: 151 · 2022: 200 · 2021: 225 · 2020: 218 · 2019: 182 · 2018: 190 · 2017: 203 · 2016: 190 · 2015: 196 · 2014: 193 · 2013: 145 · 2012: 147
- FWCI
- 141.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- PubMed Central (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Socio-Environmental Systems Modeling (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Site cant be reached (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- OPUS (Augsburg University) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Funders
- British Heart Foundation (RG/08/013/25942, RG/08/014, PG/09/002/26056, RG/07/008/23674, RG/08/014/24067)
- National Institutes of Health (n01hc085082-026, n01hc085081-021, n01hc085079-024, n01hc085083-027, n01hc085080-026, n01hc085086-022, UL1TR000062, n01hc55222-0-0-0)
- Economic and Social Research Council (ES/G007438/1)
- National Institute on Aging (R01AG023629)
- National Heart, Lung, and Blood Institute (N01 HC085086, N01 HC085079, N01 HC085083, N01 HC085080, HHSN 268200800007C, N01HC085082, U01HL080295, N01 HC055222, N01 HC085081)
- National Center for Research Resources (UL1RR025014)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes mellitus, fasting blood glucose, hyperglycemia, cause-specific mortality, cancer mortality, vascular death, premature mortality, liver cancer, pancreatic cancer, ovarian cancer, colorectal cancer, lung cancer, breast cancer, renal disease mortality, infectious disease mortality, intentional self-harm, chronic obstructive pulmonary disease, mortality risk factors
- MeSH terms
- Blood Glucose, Cause of Death, Diabetes Mellitus, Female, Humans, Hyperglycemia, Life Expectancy, Male, Middle Aged, Risk, Survival Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
